ABT vs TMO

A side-by-side look at ABT and TMO, updated throughout the trading session.

ABTABT Open ABT on Vela

TMOTMO Open TMO on Vela

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…

Live figures are refreshing. Check back in a moment.

ABT vs TMO: how they differ

Abbott Laboratories (ABT) and Thermo Fisher Scientific Inc. (TMO) are both in the Healthcare sector: ABT is classified in Medical - Devices, TMO in Medical - Diagnostics & Research. Both trade on NYSE.

ABT trades about 10.5 million shares a day on average, against 2.2 million for TMO. TMO has the higher beta (0.88 against 0.58 for ABT), meaning it has historically moved more with the broad market. Over the trailing twelve months, ABT paid $2.52 per share in dividends and TMO paid $1.84 per share.

Figures as of October 25, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.